LB Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LBRX and other ETFs, options, and stocks.About LBRX
LB Pharmaceuticals, Inc. engages in the research and development of novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its product pipeline includes LB-102, is a Phase 3-ready oral, small molecule for the treatment of acute schizophrenia, defined as a sudden and severe episode of psychotic symptoms, characterized by hallucinations, delusions, and other positive symptoms.
CEOHeather D. Turner
CEOHeather D. Turner
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2015
Founded2015
Employees—
Employees—
LBRX Key Statistics
Market cap500.16M
Market cap500.16M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume268.22K
Average volume268.22K
High today$20.46
High today$20.46
Low today$18.57
Low today$18.57
Open price$19.42
Open price$19.42
Volume285.58K
Volume285.58K
52 Week high$23.15
52 Week high$23.15
52 Week low$13.36
52 Week low$13.36
Stock Snapshot
As of today, LB Pharmaceuticals(LBRX) shares are valued at $20.15. The company's market cap stands at 500.16M.
On 2026-01-14, LB Pharmaceuticals(LBRX) stock traded between a low of $18.57 and a high of $20.46. Shares are currently priced at $20.15, which is +8.5% above the low and -1.5% below the high.
LB Pharmaceuticals(LBRX) shares are trading with a volume of 285.58K, against a daily average of 268.22K.
During the past year, LB Pharmaceuticals(LBRX) stock moved between $13.36 at its lowest and $23.15 at its peak.
During the past year, LB Pharmaceuticals(LBRX) stock moved between $13.36 at its lowest and $23.15 at its peak.
People also own
Based on the portfolios of people who own LBRX. This list is generated using Robinhood data, and it’s not a recommendation.